Mesoblast Limited on August 28, 2025, reported a
Author: Michael
Telomir Pharmaceuticals, a preclinical-stage biot
Debut targets US and Asia expansion, leveraging
Company targets metabolic imbalances in the brai
Minovia Therapeutics Ltd.
Omada Health released research demonstrating that
Portfolia has launched Women’s Health Fund IV,
Pritikin Longevity Center has released findings f
L-Nutra’s latest iteration of its Fasting Mimi
Preventive health provider teams up with Alamar